Genitourinary Syndrome Of Menopause: Clinic And Management

• Autores: Ayala-Peralta, Félix, Ayala-Moreno, Dasio, Luna-Figueroa, Antonio, Carranza-Asmat, César, Quiñones-Pereyra, Emma Ysabel, Ayala-Palomino, Richard, Quiñones-Vásquez, Luis Alberto, Ochante-Rementería, Jovanna
• Formato: artículo
• Fecha de Publicación: 2017
• Institución: Instituto Nacional Materno Perinatal
• Repositorio: Revista Peruana de Investigación Materno Perinatal
• Lenguaje: español
• OAI Identifier: oai:ojs.www.fracturae.com:article/80
• Enlace del recurso: https://investigacionmaternoperinatal.inmp.gob.pe/index.php/rpinmp/article/view/80
• Nivel de acceso: acceso abierto
• Materia: Genitourinary syndrome of menopause; Vulvovaginal atrophy; Menopause; Vaginal health; Síndrome genitourinario de la menopausia; Atrofia vulvovaginal; Menopausia; Salud vaginal

The genitourinary syndrome of menopause clinically is evident 4 to 5 years after menopause, and objective changes arepresent in 25-50% of all postmenopausal women. The most frequent symptoms are vaginal dryness ( 75%), dyspareunia(38%), and vaginal itching, vaginal discharge and pain (15%); and the diagnosis is based on clinical criteria. The principlestherapeutic are based on the restoration of urogenital physiology and relief of symptoms; including non-hormonal / lubricanttherapeutic options, systemic hormonal therapy, local estrogen therapy and other alternatives. The genitourinary syndromeof menopause is one of the most important determinants of sexual function and urogenital health, with a significant impact onthe quality of life related to female health.